Clinical Trials Browser

Phase NA × OTHER × Panitumumab × Clear all

NCT00853931 2015-12-02

Biomarker - Panitumumab Response With KRAS Wild Type MCC

Phase NA Completed

Gastrointestinal

Colorectal Neoplasms